Importance of Early Screening
- Identifies high-risk pregnancies before clinical symptoms appear.
- Allows for early preventive measures like low-dose aspirin therapy.
- Reduces risks of pre-eclampsia-related premature birth.
Book Pre-eclampsia Screening in Saudi Arabia | Lahalak Medical Platform
A precision screening designed to evaluate the risk of developing pre-eclampsia during early pregnancy, enabling proactive medical care to ensure the safety of both mother and baby throughout gestation.
Scientific name: First Trimester Pre-eclampsia Screening (PLGF/PAPP-A)
A combined screening involving blood markers (PLGF/PAPP-A), blood pressure monitoring, and uterine artery Doppler ultrasound between weeks 11-14 to assess early-onset pre-eclampsia risk accurately.
Service type
Laboratory and imaging screening
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- PLGF Biomarker Test
- PAPP-A Biomarker Test
- Mean Arterial Pressure Measurement
- Pre-eclampsia Risk Calculation
Medical Service Information
Who Should Get Screened?
- First-time pregnancies or multiple gestations (twins).
- Personal or family history of pre-eclampsia.
- Mothers with chronic hypertension, diabetes, or kidney disease.
- Expectant mothers over the age of 35.
Understanding Your Results
- Results are provided as a risk ratio (e.g., 1 in 100).
- High risk indicates a need for closer monitoring, not a certain diagnosis.
- Low risk provides significant reassurance for the pregnancy journey.
Conditions & Notices
- Must be performed between 11-14 weeks of gestation
- Bring a recent ultrasound report to confirm gestational age
Medical services you might also like
